Aims: To evaluate physicians' adjustments of insulin pump settings based on continuous glucose monitoring (CGM) for patients with type 1 diabetes and to compare these to automated insulin dose adjustments.
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Methods: A total of 26 physicians from 16 centres in Europe, Israel and South America participated in the study. All were asked to adjust insulin dosing based on insulin pump, CGM and glucometer downloads of 15 patients (mean age 16.2 AE 4.3 years, six female, mean glycated haemoglobin 8.3 AE 0.9% [66.8 AE 7.3 mmol/mol]) gathered over a 3-week period. Recommendations were compared for the relative changes in the basal, carbohydrate to insulin ratio (CR) and correction factor (CF) plans among physicians and among centres and also between the physicians and an automated algorithm, the Advisor Pro (DreaMed Diabetes Ltd, Petah Tikva, Israel). Study endpoints were the percentage of comparison points for which there was full agreement on the trend of insulin dose adjustments (same trend), partial agreement (increase/decrease vs no change) and full disagreement (opposite trend).
Results:
The percentages for full agreement between physicians on the trend of insulin adjustments of the basal, CR and CF plans were 41 AE 9%, 45 AE 11% and 45.5 AE 13%, and for complete disagreement they were 12 AE 7%, 9.5 AE 7% and 10 AE 8%, respectively. Significantly similar results were found between the physicians and the automated algorithm. The algorithm magnitude of insulin dose change was at least equal to or less than that proposed by the physicians.
Conclusions: Physicians provide different insulin dose recommendations based on the same datasets. The automated advice of the Advisor Pro did not differ significantly from the advice given by the physicians in the direction or magnitude of the insulin dosing.
K E Y W O R D S
Advisor Pro, decision support system, insulin pump settings, non-interventional survey, treatment adjustments
| INTRODUCTION
Insulin dose adjustments are an important part of the diabetes management needed to achieve target glycaemic control, as insulin dose requirements change frequently. 1 These adjustments are based mainly on detailed glucose data: capillary blood glucose and/or continuous glucose monitoring (CGM) data, and insulin delivery and meal data, such as carbohydrate intake. The increasing use of insulin pumps and CGM enables easy gathering of these valuable data from the devices.
Indeed, the number of patients who use insulin pump therapy is constantly growing and, currently, it is estimated that more than a million patients around the world use this treatment method. 2 According to the Type 1 Diabetes Exchange registry, 50% of patients with type 1 diabetes in the United States use insulin pump therapy. 3 The rate of pump use is similar in Europe, with some centres reaching rates between 70% and 93%. 4 Studies have shown that insulin pump therapy may be associated with improved overall metabolic control compared with multiple daily injections, improved glycated haemoglobin (HbA1c) levels 5, 6 and reduced rates of severe hypoglycaemia. [5] [6] [7] Optimal utilization of pump therapy requires the studying and application of a combination of theoretical knowledge and practical skills from all stakeholders, including the treating physicians, the diabetes educators, the patients and their caregivers. There is an ongoing need to tailor the pump settings, namely, the insulin correction factors (CFs), carbohydrate to insulin ratios (CRs), basal plan and insulin activity time, in order to optimize and improve glucose control. Retrospective analysis of CGM data can be a valuable means of guiding adjustments of these pump settings. 8 Nevertheless, analysis of this multitude of information may be overwhelming for many patients, caregivers and healthcare providers, as it requires extensive training and considerable time. Furthermore, there are limited data and no uniform guidelines to direct prescribers and patients regarding ways to optimize the parameters of the insulin pump settings and CGM. 9, 10 The lack of concrete guidelines leads to dose adjustments being made subjectively by healthcare professionals, which are based mostly on their individual experience and therefore greatly variable. between the two groups at the end of the study. The proportion of time spent within range for the intervention group was 52% at baseline and 57% after 3 months, and in the control group it was 57% both at baseline and after 3 months. The time spent in hypoglycaemia decreased from 3.4% at baseline to 2.5% at the end of the study for the intervention group and from 4.9% to 4.3% for the control group. 14 The aim of the present study was to compare recommendations for insulin pump settings made by different physicians treating patients with diabetes, in order to evaluate the extent of consistency among them. In addition, we compared the physicians' recommendations to those given by the automated software, the Advisor Pro.
| MATERIALS AND METHODS
This was a multicentre, multinational non-interventional survey study.
The study protocol was approved by the Rabin institutional review board (No. 000917).
We used the CareLink Pro 
| Data analysis
To compare the different recommendations of the physicians, the recommended daily adjustments were divided into 24 hourly periods (1 hour each) for basal, CR and CF plans, resulting in a total of 1080 comparison points (24 hours, 15 patients, three plans).
The physicians' recommendation points were compared for the relative changes to the patient's current pump settings in the basal, CR and CF plans between the physicians, between and within centres and between the physicians and the automated Advisor Pro algorithm.
The primary endpoints of the study were the percentage of comparison points in which there was full agreement on the trend of insulin dose adjustment (increase, decrease or no change) and full disagreement (opposite directions of insulin dose adjustments). Secondary endpoints were the percentage of comparison points that were in partial disagreement, divided into two categories, partial positive disagreement (increase insulin dose vs no change) and partial negative disagreement (decrease insulin dose vs no change).
Additional comparisons in pump setting adjustments were performed, comparing recommendations given by physicians based at the same centre, or given by faculty physicians vs fellow physicians, or
given by physicians who practise in centres with high rates of pump use (>50%) vs those with lower pump use rates (Appendix S1).
| Statistical analysis
A one-tailed, non-inferiority t test was used to assess whether the The non-inferiority margin was the 75th percentile of the mean absolute difference. Table S1 in Appendix S1.
The characteristics of the patients whose data were used for the present survey are presented in Table S2 in Appendix S1. 
| Degree of agreement in treatment adjustments
The proportion of full agreement between physicians on the direction of insulin adjustments of the basal, CR and CF settings was quite low and similar across the three assessed settings, within the range of 41% to 46% ( Table 1) . The similarity to the recommendations of the algorithm was significant, and full agreement was also within approximately the same range, at 41% to 48% (P < 0.01 for all three parameters; Figure 1A ). The proportion of complete disagreement was notably lower than the proportion of full agreement and did not differ much between the parameters (range 9.5%-12%).
Complete disagreement with the software tended to be lower than that between physicians for the CF plan (3.5%, P = 0.03), and similar for the two other plans, within a range of 8.5%-10% (P < 0.01 for both; Figure 1B ).
The proportions of partial agreement (to increase/decrease insulin dose vs no change) between physicians were similar to those observed for full agreement, and similar across recommendations (within the range of 45%-47%; Table 1 ). A significant similarity was found with the recommendations of the algorithm, and the proportion of partial agreement was~48% across recommendations (Table 1) .
Physicians working within the same centre were not found to provide similar recommendations. The level of agreement between physicians was 51.7%, 47.8% and 50.8% for sites 1, 2 and 3, respectively. The disagreement level was 4.2%, 4.7% and 9.2% for sites 1, 2 and 3, respectively. A significant difference (P = 0.018) in the distribution of the level of agreement/partial agreement/disagreement was found among the three different centres ( Figure S1 in Appendix S1).
The level of centre experience with insulin pump use had no effect on degree of agreement; the results were similar between physicians in centres in which <50% patients were using insulin pumps (n = 12) and those in which >50% of the patients were using insulin pump therapy (n = 14). The seniority of physicians did not affect the agreement either. Similar results were also found between faculty physicians (n = 13) and fellows (n = 13; Table S3 in Appendix S1). in cases of agreement in the direction of dose adjustment (increase or decrease) was found to be non-inferior between physicians and the Advisor Pro during the day as well as during the night (Table S4 in Appendix S1); therefore, according to the null hypothesis, the magnitude of change of the Advisor Pro was at least equal to or less than the advised magnitude of change proposed by the physicians. 
| Magnitude of treatment adjustments

| Number of time periods and insulin dosing parameter adjustments
Physicians tended to increase the number of basal periods: mean AE SD from 4.4 AE 1.5 to 4.9 AE 0.6 (P = 0.11) vs 7.7 AE 1.9 for the Advisor Pro (P < 0.001). The number of CR plan periods were changed by the physicians from 2.7 AE 1.4 to 3.2 AE 0.6 (P = 0.07) compared with 3.9 AE 1.3 for the Advisor Pro (P < 0.01). The number of CF plan periods were significantly changed by the physicians from 1.9 AE 1 to 2.3 AE 0.5 (P = 0.012) compared with 3.5 AE 1.1 for the Advisor Pro (P < 0.01; Table 2 ).
In instances where there was a decision to change insulin dose, physicians tended to change one, two or three variables (basal, CR or CF) at the same period of time in 28.5%, 33.5% and 23%, compared with 24.5%, 27% and 16.5% of cases, respectively, for the Advisor Pro (P < 0.001). The level of disagreement was found to be somewhat higher for the basal decisions than for the CR and CF decisions. Among centres that were studied, the level of complete disagreement differed significantly and reached as high as >10% of overall decisions at one site.
The physicians as well as the Advisor Pro tended to advise an increase in the overall dose of insulin, more by modification of the CR and CF doses than by modification of the basal insulin doses; thus, more insulin may be given as boluses and less as basal doses. The finding that more insulin should be delivered as boluses than as basal doses has been observed in pump 15 and closed-loop 16 Magnitude of insulin pump dosing adjustments in cases of full agreement for basal, carbohydrate to insulin ratio (CR) and correction factor (CF) plans. Box plot represents the median, interquartile range, minimum and maximum (n = 351) per pump settings feature. The noninferiority margin was 75th percentile of the mean absolute difference. A non-significant difference was found in the magnitude of change in cases of full agreement among physicians and between physicians and the Advisor Pro (P = 0.002 for basal and P < 0.01 for the CR and CF) Pro uses a unique algorithm that estimates the insulin requirements and was therefore able to recommend significantly more time periods.
Studies have shown the need for different insulin requirements throughout the day, which depend mainly on age and on the stage of puberty. 19, 20 Insulin pump therapy can provide a basal delivery of insulin in a more physiological way and can mimic the circadian needs.
A euglycaemic clamp study showed that it takes 2.5 to 4 hours until a considerable change in basal infusion leads to a new steady-state level, 21 therefore, up to 10 basal rates are effective with current insulin analogues.
Another difference was found for the number of parameters that were simultaneously adjusted to increase the insulin dose within the same time frame. Physicians tend to change insulin dosing in more than one variable in the same time frame more often than the Advisor Pro.
There were cases that physicians agreed upon more than others.
For example, in one case, 92% of physicians suggested a decrease in the CF. In this particular case, the patient had several correction boluses which did not result in blood glucose-lowering. The Advisor Pro provided the same recommendation. 30 The present study supports the notion that an automated decision support system that can
give automated advice on changing insulin pump settings provides similar recommendations to those given by experienced physicians, making it akin to another member in the healthcare team. In the future, this tool can be used to achieve better self-management by giving its recommendations directly to the patients. In addition, as closed-loop systems will become more available mainly for those who use pump and CGM, the main role of the Advisor Pro will be its use for those who are treated with an insulin pump and use selfmonitoring of blood glucose.
The study is limited by the fact that it may not be possible to extrapolate the findings to other groups of physicians or prescribers, such as primary healthcare providers, nurses or diabetes educators.
Our study population included adolescents and young adults and did not consider individual targets. That may have limited our ability to generalize the data to a broader population of people with type 1 diabetes. Although the Advisor Pro should not act differently in other groups of patients, the magnitude of change may vary. We may have found even larger differences among physicians as well as between physicians and the Advisor Pro if these variables had been included as insulin dosing and requirements do vary with age. The effectiveness of the insulin dosing adjustments was not evaluated in the present study because the aim was to determine whether there was agreement on pump adjustments among experienced physicians. The effectiveness of the automated system was tested in a small feasibility study that showed similarity in outcomes between recommendations given by physicians and those given by the Advisor Pro. 14 The algorithm effectiveness is being tested in a non-inferiority, multicentre, multinational, parallel-design study including 112 patients to evaluate the system's decisions compared to those made by physicians (ClinicalTrials.gov identifier: NCT03003806).
The advantage of the present study was the number of physicians that participated in the survey from different centres, which enabled us to compare, for the first time, human and automated decisions in insulin pump setting adjustments.
In conclusion, this survey showed that there was a wide variability in the ways experienced physicians chose to adjust insulin pump dosing and that automated adjustments did not differ from those given by different physicians in the direction and magnitude of insulin dosing. Future research assessing the clinical effects of recommendation strategies could serve as a basis for informed guidelines. Automated recommendations could serve as a tool for healthcare providers to make clinic visits more effective and to help adjust insulin dosing inbetween visits.
